. The company’s pipeline consists of four scientific-stage therapies. Its most advanced drug prospect is ROS1 inhibitor taletrectinib for treating lung most cancers. Nuvation is finishing two phase two pivotal scientific tests on taletrectinib.You need to never ever invest money you can't afford to lose. This point is a lot more potent with penny